Trial Profile
Efficacy and tolerability of filgrastim in patients with subacute ST-segment elevation myocardial infarction undergoing late PCI
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Filgrastim (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms G-CSF-STEMI
- 05 Nov 2010 New trial record.